Twin Tree Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-744
Closed -$1.23M 1231
2019
Q2
$1.23M Buy
744
+662
+807% +$1.15M 0.01% 753
2019
Q1
$166K Buy
82
+70
+583% +$123K ﹤0.01% 1048
2018
Q4
$15K Sell
12
-35
-74% -$53.7K ﹤0.01% 1186
2018
Q3
$89K Sell
47
-806
-94% -$1.67M ﹤0.01% 963
2018
Q2
$1.74M Buy
853
+292
+52% +$666K 0.01% 664
2018
Q1
$1.24M Buy
561
+468
+503% +$1.19M 0.01% 625
2017
Q4
$216K Buy
+93
New +$189K ﹤0.01% 885

Other funds holding BLUE

Twin Tree Management's BLUE Position: Q3 2019 in Review

Twin Tree Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 744 shares — an estimated $1.23M sold.

Twin Tree Management first reported a position in BLUE in Q4 2017 and held it in 7 quarters. The position peaked at $1.74M in Q2 2018. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Twin Tree Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Twin Tree Management sold 744 bluebird bio shares in Q3 2019, an estimated $1.23M.
  • Twin Tree Management first reported a position in bluebird bio in Q4 2017 and held it in 7 quarters.
  • Twin Tree Management's bluebird bio position peaked at $1.74M in Q2 2018.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Twin Tree Management's 13F filing for Q3 2019, filed 12 Nov 2019.